We are pleased to announce to our readers that Gland Surgery (GS) has attained its first impact factor for the 2018 citation year: 1.922.
The impact factor, as published in the annual Journal Citation Reports (JCR), is a calculation determined based on the number of citations accumulated in 2018 for manuscripts published in 2016 and 2017.
Gland Surgery is an international, open access, and peer-reviewed journal indexed by PubMed/PubMed Central and Science Citation Indexed Expanded (SCIE), providing cutting-edge findings and recent scientific advances on diagnosis, prevention, treatment and prognosis of gland diseases, such as breast, thyroid, adrenal, pancreas surgery from a range of fields as biomarkers, imaging, pathology, biology and interventional radiology etc.
The release of the journal’s first impact factor is not only a significant achievement for the journal, but it is also the beginning of developing a more significant scientific reach. Here, we would like to extend our heartfelt gratitude to all our Editorial Team Members, Guest Editors, authors, and reviewers for their significant contributions. We look forward to the continuous cooperation with all the above mentioned and those who are interested in gland disease research to bring more exciting content to readers in the coming future.